Safirstein Metcalf LLP Reminds Investors That A Class Action Lawsuit Has Been Filed Against HMS Holdings Corp. - HMS

NEW YORK, April 05, 2017 -- Safirstein Metcalf LLP reminds investors that a class action lawsuit has been filed against HMS Holdings Corp. (“HMS” or the “Company”) (NASDAQ:HMSY) in the United States District Court for District of New Jersey on behalf of persons or entities who purchased or otherwise acquired publicly traded securities of HMS from May 10, 2016 through March 2, 2017, inclusive (the “Class Period”), seeking to recover compensable damages caused by Defendants’ violations of the Securities Exchange Act of 1934.

If you purchased HMS stock during the Class Period, and would like more information about getting involved in the HMS Holdings Corp. Class Action, please call 1-800-221-0015, or email [email protected].  If you wish to serve as lead plaintiff, you must move the Court no later than May 2, 2017.

A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. Any member of the putative class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member.

The Complaint alleges that Defendants made materially false and/or misleading statements and/or failed to disclose that: (1) HMS lacked effective internal controls over financial reporting; and (2) as a result, HMS’s financial statements were materially false and misleading at all relevant times, and that when the truth was revealed, investors suffered damages.

In November of 2016, HMS revealed that there “could be a material negative impact on our future revenue in future periods” in connection with disputes over the Company’s Medicare Recovery Audit Contractor, owned by HMS, and the Centers for Medicare & Medicaid Services.  Following this news, HMS shares fell 21.5%, causing tens of millions in losses to investors.

On March 2, 2017, HMS announced it would be unable to timely file its full-year 2016 financial results, revealing that the Company had identified a “material weakness in the Company's internal controls over financial reporting,” resulting in a stock drop of another 2.5%.

About Safirstein Metcalf LLP

Safirstein Metcalf LLP focuses its practice on shareholder rights. The law firm also practices in the areas of antitrust and consumer protection.  All of the Firm’s legal endeavors are rooted in its core mission: provide investor and consumer protection.

Attorney advertising.  Prior results do not guarantee a similar outcome.

Safirstein Metcalf LLP
Peter Safirstein, Esq.
1250 Broadway
27th Floor
New York, NY  10001
1-800-221-0015